Japan drug approvals

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
News
Regional News
Diseases
Disease News
Healthcare Policies
Conferences
COVID-19
Contact
More

Use tab to navigate through the menu items.

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam

Search

Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

ipharmaservices

Nov 3, 2021

Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

ipharmaservices

Mar 12, 2021

Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

Expected best selling pharmaceutical products (drugs) in 2021

ipharmaservices

Jan 20, 2021

Expected best selling pharmaceutical products (drugs) in 2021

ipharmaservices

Jan 5, 2021

Lynparza was approved for three more indications in Japan

Merck’s Keytruda received one more indication and dosage form approval in Japan

ipharmaservices

Aug 25, 2020

Merck’s Keytruda received one more indication and dosage form approval in Japan

ipharmaservices

Jun 3, 2020

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

ipharmaservices

May 30, 2020

Astellas received approval for Xtandi in Japan for prostate cancer

AstraZeneca's Lokelma approved in Japan

ipharmaservices

Mar 29, 2020

AstraZeneca's Lokelma approved in Japan

For sponsored articles and advertisements, please write to ipharmaservices@gmail.com

Healthcare Policies

©2022 by ipharmaservices

iPharmaCenter

bottom of page